A detailed history of Grant transactions in Merck & Co., Inc. stock. As of the latest transaction made, Grant holds 7,283 shares of MRK stock, worth $724,294. This represents 0.41% of its overall portfolio holdings.

Number of Shares
7,283
Previous 7,247 0.5%
Holding current value
$724,294
Previous $897,000 7.8%
% of portfolio
0.41%
Previous 0.47%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$111.15 - $128.97 $4,001 - $4,642
36 Added 0.5%
7,283 $827,000
Q1 2024

Apr 25, 2024

BUY
$113.24 - $131.95 $6,907 - $8,048
61 Added 0.85%
7,247 $956,000
Q4 2023

Jan 30, 2024

BUY
$100.18 - $109.02 $400 - $436
4 Added 0.06%
7,186 $783,000
Q3 2023

Oct 24, 2023

SELL
$102.95 - $114.33 $10,809 - $12,004
-105 Reduced 1.44%
7,182 $739,000
Q2 2023

Jul 19, 2023

BUY
$108.61 - $118.38 $791,441 - $862,635
7,287 New
7,287 $840,000
Q4 2022

Jan 10, 2023

SELL
$87.44 - $112.11 $52,464 - $67,266
-600 Reduced 7.72%
7,177 $0
Q3 2022

Nov 02, 2022

BUY
$84.53 - $94.96 $169 - $189
2 Added 0.03%
7,777 $759,000
Q2 2022

Jul 20, 2022

BUY
$83.49 - $94.64 $166 - $189
2 Added 0.03%
7,775 $727,000
Q1 2022

Apr 25, 2022

BUY
$73.51 - $82.4 $571,393 - $640,495
7,773 New
7,773 $666,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Grant Portfolio

Follow Grant and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grant, based on Form 13F filings with the SEC.

News

Stay updated on Grant with notifications on news.